CLINICAL_TRIALS ClinicalTrials.gov record update

Long-term Study of Immune Response Persistence of GSK Biologicals' 2-dose Thiomersal-free Engerix™-B and 3-dose Preservative-free Engerix™-B Vaccines in Subjects Aged 11-15 Yrs

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00343915
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:16.263049+00:00
Published At: 2009-03-31T00:00:00+00:00
Record Updated At: 2019-06-10
Results Posted At: 2009-03-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-06-10"
protocolSection.identificationModule.nctId: "NCT00343915"
protocolSection.identificationModule.officialTitle: "Long-term Study of Immune Response Persistence of GSK Biologicals\u0027 2-dose Thiomersal-free Engerix\u2122-B and 3-dose Preservative-free Engerix\u2122-B Vaccines in Subjects Aged 11-15 Yrs"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2009-03-31"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.